Home
ISTO Biologics

ISTO Biologics Market Share Analysis for July 2026

Brian Barnes, PhD and Nathan Taylor appointed CEO and President; Don Brown stepping down as CEO and will remain on the Board of Directors.

Industry: N/A

Domainistobiologics.com

Year Founded2016

Employees51 - 200

Annual Revenue$25M - $50M

ISTO Biologics

ISTO Biologics (including company regionals)

istobiologics.com

See more website traffic and engagement information

ISTO Biologics Revenue up to July 2026 is 25M - 50M

revenue generated by ISTO Biologics top domains

ISTO Biologics top domains revenue over 3 years

Revenue for ISTO Biologics top domains

istobiologics.com25M - 50M

See more with Sales Intelligence

Total visits to ISTO Biologics's top domains

Understand ISTO Biologics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

istobiologics.com4.6K

See more with Sales Intelligence

Avg. visit duration in ISTO Biologics's top domains

Analyze ISTO Biologics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

istobiologics.com00:00:11

See more with Sales Intelligence

Avg. pageviews on ISTO Biologics's top domains

See how ISTO Biologics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

istobiologics.com1.74

See more with Sales Intelligence

ISTO Biologics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by ISTO Biologics

These are the website technologies, by industry, used by ISTO Biologics top domains

Advertising (4)

DoubleClick

Social (4)

Instagram

Content Management System (3)

WordPress

Email Services (3)

Microsoft Exchange Online

More Technologies

11

See all

News & Signals from ISTO Biologics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsIsto Biologics acquired NovaBone Products, LLC for $60.7M on Aug 4th '26.Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone.

NewsHalma plc sold assets to Isto Biologics in the amount of $60M on Aug 4th '26.Halma completes $60m sale of NovaBone to Isto Biologics.

NewsKeensight Capital acquires Isto Biologics for $1B.Keensight Capital acquires majority stake in Isto Biologics, a leading orthobiologics player, from Thompson Street Capital Partners.